An EU-funded chemist has won a share of the Nobel Prize in Chemistry for a technique that enables researchers to peer into the nanoworld of individual molecules.
Professor Stefan W. Hell, who has received EU funding multiple times, won the prize alongside US researchers Professor William E. Moerner and Dr Eric Betzig. The trio are credited with creating microscopes that can see at a greater resolution than half the wavelength of light.
That’s significant because Ernst Abbe, a famous microscopist in the 1800s, had used mathematics to show that scientists would never be able to view organisms with a microscope which were smaller than that.
‘So much physics happened in the twentieth century that it was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier that was coined in 1873 or so,’ Prof. Hell said in an audio interview posted on the Nobel Prize website. ‘I felt that there had to be something.’
In 1994 as a post-doctoral researcher at the University of Turku, in Finland, he published a theoretical article outlining how he could use fluorescence techniques to build a kind of flashlight which would generate an image of far greater resolution than previously achieved.
‘It was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier.’
Professor Stefan W. Hell
He received funding from Marie Skłodowska-Curie Actions (MSCA) to work on so-called fluorescence microscopy and then was invited to the Max Planck Institute for Biophysical Chemistry in Germany. Here he managed to develop one of these microscopes, and in the year 2000 he imaged an E.coli bacterium at a never-before-seen resolution.
Having benefitted from the MSCA grant himself, Professor Hell later coordinated three MSCA individual fellowships. He and his fellow researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen also participated in collaborative projects funded by the EU, including the FLUODIAMON project which looked at using fluorescence microscopy to detect cancer. This year, three Nobel Prizes – for Physiology/Medicine, Physics and Chemistry – have all had links to the EU’s MSCA programme.
European Commissioner Androulla Vassiliou, responsible for the MCSA scheme and European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said in a joint statement: ‘Outstanding researchers like Stefan W. Hell are an excellent example of what European research mobility can achieve.’
Prof. Moerner and Dr Betzig, developed a separate method called single-molecule microscopy.
These discoveries mean that researchers can now track proteins involved in diseases like Parkinson’s and Alzheimer’s, and follow individual proteins in fertilized eggs as these divide into embryos.
When an outbreak strikes, speed is critical. Health workers must act quickly not only to contain and treat an emerging or re-emerging disease, but also to use this window to evaluate potential treatments and vaccines. And the challenge becomes even greater in sub-Saharan Africa when you’re trying to develop new approaches in the face of multiple emerging diseases.
Understanding the progression from the stepping reflex to independent walking could help find new therapies for children with cerebral palsy (CP) – a movement disability caused by brain damage before, during or shortly after birth.
Nature provides people with everything from food and water to timber, textiles, medicinal resources and pollination of crops. Now, a new approach aims to measure exactly what a specific ecosystem supplies in order to incentivise decision-makers and businesses to help combat biodiversity loss.
Europe’s position on privacy, regulation and competition could be a key way to attract entrepreneurs who share those values but there is still some work to do in encouraging ambition, according to Nicklas Bergman, a Swedish entrepreneur and technology investor. Over the past two years, he and other entrepreneurs have advised the European Commission on the design of the European Innovation Council (EIC), an initiative to support companies, researchers and entrepreneurs hoping to start their own business or scale up their projects internationally. The second phase of the pilot was launched on 18 March 2019.
To protect species, we need to speak the language of business, say experts.
He has advised the EU on its new European Innovation Council.
Species loss needs urgent international action, says Prof. Georgina Mace.